Greetings to everyone who is interested in looking for perspective and revolutionary projects in blockchain! Recently, I often come across a lot of projects that don't represent anything new and it becomes more difficult to single out the most promising startup. Not long ago I heard about Shivom. I got acquainted with the project for several days and concluded that it is leading for me at the moment among all the ICOs. I would like to share with everyone for the general attraction of attention, as worthwhile projects deserve maximum publicity.
Shivom is positioned as a decentralized cloud storage of human DNA data, the genome on a blockchain, followed by an analysis of all the data provided. Let's look at what are the advantages of the development of technologies related to the human genome and his/her DNA.
Such science as genomics appeared several years ago. This science studies human genetic material and already today is the basis for such disciplines as: pharmacogenomics, microbial genomics, genomic medicine, etc. But the most important point is the application in the field of diagnosis, treatment and prevention of thousands of genetic diseases inherent in the development of which genetic factors are involved. First of all, these are diseases associated with cardiovascular disorders, diabetes mellitus, mental and neurological disorders, etc. Positive results in this area can give access to the little-known term "book of life" - this is the exact biochemical gene code of each of the 100,000 genes that make up the human genome and are direct on the path to immortality and the development of cloning. The gene market itself amounts to $ 200 billion a year and only a few players gain access to this market without the permission of individuals from the participants in the genetics relationship (meaning those people who provide their genes for research).
Achievements:
In my opinion, the achievements of Shivom at the moment is the fact, that the project concluded a partnership with GTG Labs, the basis of which was a conference in NASDAQ (which I recommend to familiarize with on the medium channel of the project). Owing to GTG Labs project will have access to the development of new genetic panels and accredited laboratories in the United States. Besides it, also signed an agreement with the state government of Andhra Pradesh in India to get access to a total population of over 50 million for research and the beginning of the pilot launch of the project in a major cancer center. Another interesting fact is that on the part of venture funds, a total of more than 40,000+ ETHs were collected. I don't know your opinion, but I suppose this amount of money collected before the launch of Pre-ICO conveys the real cost of the project for our society. For me, among other projects, Shivom is distinguished by the scale and volume of the market for which is planning the output. Also, the project actively and openly declares itself within the framework of partnership agreements, and slowly but surely begins its work to the public announcement of the public sale, and moving away from the concept to working product.
Basic information of the project:
The essence of realization of Shivom's intentions lies in the fact that when, for example, a patient has data about his genome, i.e. DNA, he has the right to dispose of them. In this case, any person has the right to provide their DNA data at the Shivom research center. The project in turn implements these data for research and in the subsequent withdrawal of the antigen for the development of any kind of disease. For example, a person who has never suffered from diabetes mellitus can help to avoid this type of disease to the fetus of the hereditary carrier of the disease. Due to the above issues and solutions, anyone can sell their DNA data, receive profits, and find the right treatment for their ailments.
The Shivom goals:
The main goal of this startup direction is the materialization of the ecosystem and the mechanism for submitting this population's DNA primarily to receive remuneration. The essence of these payments is a multiple return in the form of realizing these very DNA data in the development of pharmaceuticals, goaled at curing incurable at this moment diseases and diseases transmitted by inheritance, etc.
Since Shivom is not one of those who are interested in the development of this area, thanks to the platform and blockchain technologies will be possible all kinds of exchanges, sales and awards for the most claiming of your DNA genomes for the benefit of pharmaceutical development.
All obtained DNA data will be transmitted through a smart contract and stored in blockchain. This ensures the reliability and transparency of the user data. This technology as a blockchain has proved to be a reliable way of storing and transmitting data, because it can safely store any information without fear that it will fall into the hands of a third party and allow for rapid exchange of data between the two sides.
Conclusion:
Team work and revolutionary approach to the market economy with a human DNA, which can dispose of every one of us, and reap the benefits of the two sides, gives the right to judge that this project will soon declare itself in the top 100 currencies. Public sale has not yet begun, but there are already mass discussions and the first steps to self-realization of Shivom. The only downside is the unconsciousness of the society about the development and achievements of the project in connection with which I recommend that you visit their medium page more often.
General information about the tokens Shivom
- Name: OmiX
- Price: 1 OmiX = 0.0775 USD
- Total issue: 3 000 000 000 OmiX
- Number of tokens allocated to ICO: 990 000 000 OmiX
- Hard Cap: $ 40,700,000
- Dates Token Sale: 16.04.2018 - 16.05.2018
- Cryptocurrency for investments: ETH, BTC, USD There is no information about the burning of tokens*
Information resources of the project:
- Official site
- WhitePaper
- ANN BTT (rus)
- ANN BTT (eng)
- Bounty
- Telegram https://t.me/projshivom_ru ; https://t.me/projshivom
My Details: